{"organizations": [], "uuid": "0baeca9cb7346ee5f8c00186df701edd822b8205", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-avexis-enters-agreement-to-be-acqu/brief-avexis-enters-agreement-to-be-acquired-by-novartis-for-8-7-bln-idUSFWN1RL01V", "country": "US", "domain_rank": 408, "title": "BRIEF-AveXis Enters Agreement To Be Acquired By Novartis For $8.7 Bln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-09T07:49:00.000+03:00", "replies_count": 0, "uuid": "0baeca9cb7346ee5f8c00186df701edd822b8205"}, "author": "", "url": "https://www.reuters.com/article/brief-avexis-enters-agreement-to-be-acqu/brief-avexis-enters-agreement-to-be-acquired-by-novartis-for-8-7-bln-idUSFWN1RL01V", "ord_in_thread": 0, "title": "BRIEF-AveXis Enters Agreement To Be Acquired By Novartis For $8.7 Bln", "locations": [], "entities": {"persons": [{"name": "nov", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "novartis", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "avexis inc", "sentiment": "none"}, {"name": "novartis ag", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9, 2018 / 4:49 AM / Updated 16 minutes ago BRIEF-AveXis Enters Agreement To Be Acquired By Novartis For $8.7 Bln Reuters Staff \nApril 9 (Reuters) - AveXis Inc: \n* AVEXIS ENTERS AGREEMENT TO BE ACQUIRED BY NOVARTIS AG FOR $8.7 BILLION \n* SAYS OFFER REPRESENTS A PREMIUM OF 88 PERCENT TO AVEXISâ€™ CLOSING PRICE ON APRIL 6, 2018 \n* ENTERED AGREEMENT AND PLAN OF MERGER WITH NOVARTIS PURSUANT TO WHICH NOVARTIS WILL ACQUIRE AVEXIS FOR $218 PER SHARE \n* SAYS TRANSACTION WAS UNANIMOUSLY APPROVED BY BOARDS OF DIRECTORS OF BOTH COMPANIES. Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-09T07:49:00.000+03:00", "crawled": "2018-04-09T08:11:38.008+03:00", "highlightTitle": ""}